FINWIRES · TerminalLIVE
FINWIRES

ASX Preview: Australian Shares to Rise on Renewed US-Iran Talks Optimism; Qantas Airways Raises Fiscal 2026 Fuel Cost Forecast

-- Australian shares are poised to rise on Tuesday after oil markets were shaken by escalating Middle East tensions, as the US moves to restrict shipping through the Strait of Hormuz.

US President Donald Trump said Iran had reached out to restart negotiations after failed weekend talks in Islamabad, Pakistan, as investors weighed the risk of further disruption to global energy supplies.

Overnight, the S&P 500, the Nasdaq Composite, and the Dow Jones Industrial Average rose 1%, 1.2%, and 0.6%, respectively.

In the macroeconomy, Australia's wages rose 0.8% in the March quarter while employment added about 23,000 jobs, pointing to a steady but gradually cooling labor market with wage growth stabilizing near a new baseline, Commonwealth Bank of Australia (ASX:CBA) said in a Monday report.

In corporate news, Qantas Airways (ASX:QAN) now expects fuel cost for the second half of fiscal 2026 to be AU$3.1 billion to AU$3.3 billion, as February jet refining margins peaked at about $120 per barrel.

Westpac Banking (ASX:WBC, NZE:WBC) will boost credit provisions for customers in energy-intensive sectors due to the volatility and economic uncertainty created by the Middle East conflict.

Australia's benchmark index fell 0.4% or 34.6 points to close at 8,926 on Monday.

Related Articles

Asia

Beijing Enlight Media Q1 Profit Falls 99%; Shares Down 8%

Beijing Enlight Media Co (SHE:300251) posted first-quarter attributable net profit of 23.3 million yuan, down 99% from 2.02 billion yuan the previous year.Earnings per share went down to 0.01 yuan from 0.69 yuan, according to a Wednesday filing with the Shenzhen bourse.Operating revenue fell 94% year over year to 190.6 million yuan from 2.97 billion yuan.Shares of the media company were down 8% in recent trade.

$SHE:300251
Asia

Enlight Media 2025 Profit Jumps 473%; Shares Fall 7%

Beijing Enlight Media (SHE:300251) posted 2025 attributable net profit of 1.67 billion yuan, up 473% from 292.0 million yuan the previous year.Earnings per share went up to 0.57 yuan from 0.10 yuan, according to a Wednesday filing with the Shenzhen bourse.Operating revenue jumped 155% year over year to 4.04 billion yuan from 1.59 billion yuan.Shares of the media company were down 7% in recent trade.

$SHE:300251
Asia

CR Double-Crane Pharma Gets Nod to Name Unit as Marketer of Endometriosis Drug

China Resources Double-Crane Pharmaceutical (SHA:600062) received approval from the National Medical Products Administration to change the marketing authorization holder of dienogest tablets, according to a Shanghai bourse filing on Wednesday.Under the approved supplementary application, the pharmaceutical company's subsidiary, CR Zizhu Pharmaceutical, becomes the marketing authorization holder, as well as the manufacturer of the endometriosis drug.

$SHA:600062